Atlas Trials

A Study to Assess the Safety and Efficacy of Levoketoconazole in the Treatment of Endogenous Cushing's Syndrome.

Clinical trial NCT03277690 · COMPLETED

Trial details

NCT number
NCT03277690
Sponsor
Cortendo AB
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Endogenous Cushing's Syndrome
Start date
2017-09-26
Primary completion
2020-06-30
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.